Clinical Review: Current Concept
Venous Thromboembolic Events in the Rehabilitation Setting
Brian M. Kelly DO,
Brian M. Yoder MD,
Chi-Tsai Tang MD,
Thomas W. Wakefield MD,
Corresponding Author
Brian M. Kelly DO
Department of Physical Medicine and Rehabilitation, University of Michigan Health System, 325 Eisenhower, Suite 200, Ann Arbor, MI 48108
Disclosure: nothing to discloseAddress correspondence to: B.M.K.Search for more papers by this authorBrian M. Yoder MD
University Physician Group and Department of Physical Medicine and Rehabilitation, Rehabilitation Institute of Michigan, Detroit, MI
Disclosure: nothing to discloseDeceased.
Search for more papers by this authorChi-Tsai Tang MD
Physical Medicine and Rehabilitation, Washington University Orthopedics, St. Louis, MO
Disclosure: nothing to discloseSearch for more papers by this authorThomas W. Wakefield MD
Department of Surgery, University of Michigan Health System, Ann Arbor, MI
Disclosure: nothing to discloseSearch for more papers by this authorBrian M. Kelly DO,
Brian M. Yoder MD,
Chi-Tsai Tang MD,
Thomas W. Wakefield MD,
Corresponding Author
Brian M. Kelly DO
Department of Physical Medicine and Rehabilitation, University of Michigan Health System, 325 Eisenhower, Suite 200, Ann Arbor, MI 48108
Disclosure: nothing to discloseAddress correspondence to: B.M.K.Search for more papers by this authorBrian M. Yoder MD
University Physician Group and Department of Physical Medicine and Rehabilitation, Rehabilitation Institute of Michigan, Detroit, MI
Disclosure: nothing to discloseDeceased.
Search for more papers by this authorChi-Tsai Tang MD
Physical Medicine and Rehabilitation, Washington University Orthopedics, St. Louis, MO
Disclosure: nothing to discloseSearch for more papers by this authorThomas W. Wakefield MD
Department of Surgery, University of Michigan Health System, Ann Arbor, MI
Disclosure: nothing to discloseSearch for more papers by this authorDisclosure: nothing to disclose
Deceased.
This CME activity is designated for 1.0 AMA PRA Category 1 Credit™ and can be completed online at me.aapmr.org. Log on to www.me.aapmr.org, go to Lifelong Learning (CME) and select Journal-based CME from the drop down menu. This activity is FREE to AAPM&R members and $25 for non-members.
Disclosure Key can be found on the Table of Contents and at www.pmrjournal.org
Abstract
Venous thromboembolism (VTE) is a disease entity that encompasses both deep venous thrombosis and pulmonary embolism. During the past decade there have been significant advances in the understanding of prophylaxis and treatment of VTE. There is an extensive research base from which conclusions can be drawn, but the heterogeneity within the rehabilitation patient population makes the development of rigid VTE protocols challenging and overwhelming for the busy clinician. Given the prevalence of this condition and its associated morbidity and mortality, we review the evidence for the prevention, identification, and optimal treatment of VTE in the rehabilitation population. Our goal is to highlight studies that have the most clinical applicability for the care of VTE patients from a physiatrist's perspective. At times, information about acute care protocols is included in our discussion because these situations are encountered during the consultation process that identifies patients for rehabilitation needs.
References
- 1E.L. Siegler, M.G. Stineman, G. Maislin. Development of complications during rehabilitation. Arch Intern Med. 1994; 154: 2185–2190.
- 2D. Chen, D.F. AppleJr, L.M. Hudson, R. Bode. Medical complications during acute rehabilitation following spinal cord injury—current experience of the Model Systems. Arch Phys Med Rehabil. 1999; 80: 1397–1401.
- 3B. Burke, R. Kumar, V. Vickers, E. Grant, E. Scremin. Deep vein thrombosis after lower limb amputation. Am J Phys Med Rehabil. 2000; 79: 145–149.
- 4E.J. Roth, L. Lovell, R.L. Harvey, A.W. Heinemann, P. Semik, S. Diaz. Incidence of and risk factors for medical complications during stroke rehabilitation. Stroke. 2001; 32: 523–529.
- 5M.L. Carney, P. Ullrich, P. Esselman. Early unplanned transfers from inpatient rehabilitation. Am J Phys Med Rehabil. 2006; 85: 453–460, quiz 461-453.
- 6A.F. Shorr. The pharmacoeconomics of deep vein thrombosis treatment. Am J Med. 2007; 120(10 Suppl 2): S35–S41.
- 7G. de Lissovoy. Economic issues in the treatment and prevention of deep vein thrombosis from a managed care perspective. Am J Manage Care. 2001; 7(17 Suppl): S535–S538, discussion S538-544.
- 8A. Merkel. Origin and natural history of deep vein thrombosis of the legs. Sem Vasc Med. 2005; 5: 10.
- 9J.A. Heit, M.D. Silverstein, D.N. Mohr, T.M. Petterson, W.M. O'Fallon, L.J. Melton3rd. Risk factors for deep vein thrombosis and pulmonary embolism: A population-based case-control study. Arch Intern Med. 2000; 160: 809–815.
- 10J.W. Blom, C.J. Doggen, S. Osanto, F.R. Rosendaal. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005; 293: 715–722.
- 11F.A. AndersonJr, H.B. Wheeler, R.J. Goldberg, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991; 151: 933–938.
- 12G.D. Motykie, L.P. Zebala, J.A. Caprini, et al. A guide to venous thromboembolism risk factor assessment. J Thromb Thrombolysis. 2000; 9: 253–262.
- 13R.H. White, H. Zhou, P.S. Romano. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost. 2003; 90: 446–455.
- 14W. Ageno, A. Squizzato, D. Garcia, D. Imberti. Epidemiology and risk factors of venous thromboembolism. Semin Thromb Hemost. 2006; 32: 651–658.
- 15G. Agnelli, C. Becattini. Treatment of DVT: How long is enough and how do you predict recurrence. J Thromb Thrombolysis. 2008; 25: 37–44.
- 16R.D. Hull, J. Hirsh, C.J. Carter, et al. Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med. 1983; 98: 891–899.
- 17D.L. Rollins, C.M. Semrow, M.L. Friedell, W.E. Lloyd, D. Buchbinder. Origin of deep vein thrombi in an ambulatory population. Am J Surg. 1988; 156: 122–125.
10.1016/S0002-9610(88)80370-2 Google Scholar
- 18M. Meignan, J. Rosso, H. Gauthier, et al. Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis. Arch Intern Med. 2000; 160: 159–164.
- 19C. Kearon. Natural history of venous thromboembolism. Circulation. 2003; 107(23 Suppl 1): I22–I30.
- 20A. Markel. Origin and natural history of deep vein thrombosis of the legs. Semin Vasc Med. 2005; 5: 65–74.
- 21C.I. Lagerstedt, C.G. Olsson, B.O. Fagher, B.W. Oqvist, U. Albrechtsson. Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet. 1985; 2: 515–518.
- 22S. Schulman, A.S. Rhedin, P. Lindmarker, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med. 1995; 332: 1661–1665.
- 23P. Prandoni, A.W. Lensing, A. Cogo, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996; 125: 1–7.
- 24H. Decousus, A. Leizorovicz, F. Parent, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med. 1998; 338: 409–415.
- 25P.O. Hansson, J. Sorbo, H. Eriksson. Recurrent venous thromboembolism after deep vein thrombosis: Incidence and risk factors. Arch Intern Med 27. 2000; 160: 769–774.
- 26M. Cushman, R.J. Glynn, S.Z. Goldhaber, et al. Hormonal factors and risk of recurrent venous thrombosis: The prevention of recurrent venous thromboembolism trial. J Thromb Haemost. 2006; 4: 2199–2203.
- 27J.A. Heit, M.D. Silverstein, D.N. Mohr, T.M. Petterson, W.M. O'Fallon, L.J. Melton3rd. Predictors of survival after deep vein thrombosis and pulmonary embolism: A population-based, cohort study. Arch Intern Med. 1999; 159: 445–453.
- 28J.A. Heit, D.N. Mohr, M.D. Silverstein, T.M. Petterson, W.M. O'Fallon, L.J. Melton3rd. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: A population-based cohort study. Arch Intern Med. 2000; 160: 761–768.
- 29A. Kommareddy, M.H. Zaroukian, H.I. Hassouna. Upper extremity deep venous thrombosis. Semin Thromb Hemost. 2002; 28: 89–99.
- 30T. Arnhjort, L.M. Persson, S. Rosfors, U. Ludwigs, G. Larfars. Primary deep vein thrombosis in the upper limb: A retrospective study with emphasis on pathogenesis and late sequelae. Eur J Intern Med. 2007; 18: 304–308.
- 31 R.J. Mason, J.F. Murray, B.C. Broaddus, et al., eds. Murray & Nadel's Textbook of Respiratory Medicine. 4th ed. Philadelphia: Saunders. 2005.
- 32W.H. Geerts, D. Bergqvist, G.F. Pineo, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008; 133(6 Suppl): 381S–453S.
- 33P. Prandoni, E. Bernardi, A. Marchiori, et al. The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study. BMJ. 2004; 329: 484–485.
- 34D.P. Brandjes, H.R. Buller, H. Heijboer, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet. 1997; 349: 759–762.
- 35D.N. Mohr, M.D. Silverstein, J.A. Heit, T.M. Petterson, W.M. O'Fallon, L.J. Melton. The venous stasis syndrome after deep venous thrombosis or pulmonary embolism: A population-based study. Mayo Clin Proc. 2000; 75: 1249–1256.
- 36C. Kearon, S.R. Kahn, G. Agnelli, S. Goldhaber, G.E. Raskob, A.J. Comerota. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 8th ed. Chest. 2008; 133(6 Suppl): 454S–545S.
- 37S.R. Kahn, E.A. Elman, C. Bornais, M. Blostein, P.S. Wells. Post-thrombotic syndrome, functional disability and quality of life after upper extremity deep venous thrombosis in adults. Thromb Haemost. 2005; 93: 499–502.
- 38S.R. Kahn, J.S. Ginsberg. Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med. 2004; 164: 17–26.
- 39A.A. Ashrani, J.A. Heit. Incidence and cost burden of post-thrombotic syndrome. J Thromb Thrombolysis. 2009; 28: 465–476.
- 40D.N. Kolbach, M.W. Sandbrink, K. Hamulyak, H.A. Neumann, M.H. Prins. Non-pharmaceutical measures for prevention of post-thrombotic syndrome. Cochrane Database Syst Rev. 2004; (1): CD004174.
- 41J.S. Ginsberg, D. Magier, B. Mackinnon, M. Gent, J. Hirsh. Intermittent compression units for severe post-phlebitic syndrome: A randomized crossover study. CMAJ. 1999; 160: 1303–1306.
- 42J. Trujillo-Santos, E. Perea-Milla, A. Jimenez-Puente, et al. Bed rest or ambulation in the initial treatment of patients with acute deep vein thrombosis or pulmonary embolism: Findings from the RIETE registry. Chest. 2005; 127: 1631–1636.
- 43P.S. Wells, C. Owen, S. Doucette, D. Fergusson, H. Tran. Does this patient have deep vein thrombosis?. JAMA. 2006; 295: 199–207.
- 44S.S. Anand, P.S. Wells, D. Hunt, P. Brill-Edwards, D. Cook, J.S. Ginsberg. Does this patient have deep vein thrombosis?. JAMA. 1998; 279: 1094–1099.
- 45M. Righini, C. Goehring, H. Bounameaux, A. Perrier. Effects of age on the performance of common diagnostic tests for pulmonary embolism. Am J Med. 2000; 109: 357–361.
- 46J.L. Bosson, C. Barro, B. Satger, P.H. Carpentier, B. Polack, G. Pernod. Quantitative high D-dimer value is predictive of pulmonary embolism occurrence independently of clinical score in a well-defined low risk factor population. J Thromb Haemost. 2005; 3: 93–99.
- 47J.L. Bosson, J. Labarere, M.A. Sevestre, et al. Deep vein thrombosis in elderly patients hospitalized in subacute care facilities: A multicenter cross-sectional study of risk factors, prophylaxis, and prevalence. Arch Intern Med. 2003; 163: 2613–2618.
- 48D. Imberti. D-dimer testing: Advantages and limitations in emergency medicine for managing acute venous thromboembolism. Intern Emerg Med. 2007; 2: 70–71.
- 49S.W. Heim, J.M. Schectman, M.S. Siadaty, J.T. Philbrick. D-dimer testing for deep venous thrombosis: A metaanalysis. Clin Chem. 2004; 50: 1136–1147.
- 50M.C. Janssen, H. Wollersheim, B. Verbruggen, I.R. Novakova. Rapid D-dimer assays to exclude deep venous thrombosis and pulmonary embolism: Current status and new developments. Semin Thromb Hemost. 1998; 24: 393–400.
- 51M.C. Janssen, A.E. Heebels, M. de Metz, et al. Reliability of five rapid D-dimer assays compared to ELISA in the exclusion of deep venous thrombosis. Thromb Haemost. 1997; 77: 262–266.
- 52P.S. Wells, D.R. Anderson, M. Rodger, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med. 2003; 349: 1227–1235.
- 53M.N. Akman, N. Cetin, M. Bayramoglu, I. Isiklar, S. Kilinc. Value of the D-dimer test in diagnosing deep vein thrombosis in rehabilitation inpatients. Arch Phys Med Rehabil. 2004; 85: 1091–1094.
- 54B. Birdwell. Recent clinical trials in the diagnosis of deep-vein thrombosis. Curr Opin Hematol. 1999; 6: 275–279.
10.1097/00062752-199909000-00001 Google Scholar
- 55M. Tan, C.J. van Rooden, R.E. Westerbeek, M.V. Huisman. Diagnostic management of clinically suspected acute deep vein thrombosis. Br J Haematol. 2009; 146: 347–360.
- 56M.B. Streiff. Diagnosis and initial treatment of venous thromboembolism in patients with cancer. J Clin Oncol. 2009; 27: 4889–4894.
- 57S. Goodacre, F. Sampson, M. Stevenson, et al. Measurement of the clinical and cost-effectiveness of non-invasive diagnostic testing strategies for deep vein thrombosis. Health Technol Assess. 2006; 10: 1–168, iii-iv.
- 58J.J. Michiels, A. Gadisseur, M. Van Der Planken, et al. A critical appraisal of non-invasive diagnosis and exclusion of deep vein thrombosis and pulmonary embolism in outpatients with suspected deep vein thrombosis or pulmonary embolism: How many tests do we need?. Int Angiol. 2005; 24: 27–39.
- 59P.S. Wells, D.R. Anderson. Modern approach to diagnosis in patients with suspected deep vein thrombosis. Haemostasis. 1999; 29(Suppl S1): 10–20.
- 60P.S. Wells, D.R. Anderson, J. Ginsberg. Assessment of deep vein thrombosis or pulmonary embolism by the combined use of clinical model and noninvasive diagnostic tests. Semin Thromb Hemost. 2000; 26: 643–656.
- 61P.S. Wells. Advances in the diagnosis of venous thromboembolism. J Thromb Thrombolysis. 2006; 21: 31–40.
10.1007/s11239-006-5573-x Google Scholar
- 62P.S. Wells, J.S. Ginsberg, D.R. Anderson, et al. Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med. 1998; 129: 997–1005.
- 63P.S. Wells, D.R. Anderson, M. Rodger, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: Increasing the models utility with the SimpliRED D-dimer. Thromb Haemost. 2000; 83: 416–420.
- 64J.R. Mayo, M. Remy-Jardin, N.L. Muller, et al. Pulmonary embolism: Prospective comparison of spiral CT with ventilation-perfusion scintigraphy. Radiology. 1997; 205: 447–452.
- 65P.D. Stein, S.E. Fowler, L.R. Goodman, et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med. Jun 1. 2006; 354(22): 2317–2327.
- 66M.A. Rodger, M. Carrier, G.N. Jones, et al. Diagnostic value of arterial blood gas measurement in suspected pulmonary embolism. Am J Respir Crit Care Med. 2000; 162: 2105–2108.
- 67P.D. Stein, P.K. Woodard, J.G. Weg, et al. Diagnostic pathways in acute pulmonary embolism: Recommendations of the PIOPED II Investigators. Radiology. 2007; 242: 15–21.
- 68V. Kadyan, D.M. Clinchot, S.C. Colachis. Cost-effectiveness of duplex ultrasound surveillance in spinal cord injury. Am J Phys Med Rehabil. 2004; 83: 191–197.
- 69G.J. Merli, G.J. Herbison, J.F. Ditunno, et al. Deep vein thrombosis: Prophylaxis in acute spinal cord injured patients. Arch Phys Med Rehabil. 1988; 69: 661–664.
- 70P. Myllynen, M. Kammonen, P. Rokkanen, O. Bostman, M. Lalla, E. Laasonen. Deep venous thrombosis and pulmonary embolism in patients with acute spinal cord injury: A comparison with nonparalyzed patients immobilized due to spinal fractures. J Trauma. 1985; 25: 541–543.
- 71J. Seifert, G. Lob, E. Stoephasius, J. Probst, W. Brendel. Blood flow in muscles of paraplegic patients under various conditions measured by a double isotope technique. Paraplegia. 1972; 10: 185–191.
- 72E.C. Rossi, D. Green, J.S. Rosen, S.M. Spies, J.S. Jao. Sequential changes in factor VIII and platelets preceding deep vein thrombosis in patients with spinal cord injury. Br J Haematol. 1980; 45: 143–151.
- 73K. Winther, G. Gleerup, K. Snorrason, F. Biering-Sorensen. Platelet function and fibrinolytic activity in cervical spinal cord injured patients. Thromb Res. 1992; 65: 469–474.
- 74G. Ersoz, H. Ficicilar, M. Pasin, R. Yorgancioglu, S. Yavuzer. Platelet aggregation in traumatic spinal cord injury. Spinal Cord. 1999; 37: 644–647.
- 75M.L. Sipski, J.S. Richards. Spinal cord injury rehabilitation: State of the science. Am J Phys Med Rehabil. 2006; 85: 310–342.
- 76T. Jones, V. Ugalde, P. Franks, H. Zhou, R.H. White. Venous thromboembolism after spinal cord injury: Incidence, time course, and associated risk factors in 16,240 adults and children. Arch Phys Med Rehabil. 2005; 86: 2240–2247.
- 77W.H. Geerts, R.M. Jay, K.I. Code, et al. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med. 1996; 335: 701–707.
- 78 Prevention of venous thromboembolism in the rehabilitation phase after spinal cord injury. Prophylaxis with low-dose heparin or enoxaparin. J Trauma. 2003; 54: 1111–1115.
- 79 Prevention of thromboembolism in spinal cord injury. Consortium for Spinal Cord Medicine. J Spinal Cord Med. 1997; 20: 259–283.
- 80 Prevention of venous thromboembolism in the acute treatment phase after spinal cord injury. A randomized, multicenter trial comparing low-dose heparin plus intermittent pneumatic compression with enoxaparin. J Trauma. 2003; 54: 1116–1124, discussion 1125-1116.
- 81W.H. Geerts, D. Bergqvist, G.F. Pineo, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133: 381S–453S.
- 82S. Aito, A. Pieri, M. D'Andrea, F. Marcelli, E. Cominelli. Primary prevention of deep venous thrombosis and pulmonary embolism in acute spinal cord injured patients. Spinal Cord. 2002; 40: 300–303.
- 83J.C. Furlan, M.G. Fehlings. Role of screening tests for deep venous thrombosis in asymptomatic adults with acute spinal cord injury: An evidence-based analysis. Spine (Phila Pa 1976). 2007; 32: 1908–1916.
- 84M. Powell, S. Kirshblum, K.C. O'Connor. Duplex ultrasound screening for deep vein thrombosis in spinal cord injured patients at rehabilitation admission. Arch Phys Med Rehabil. 1999; 80: 1044–1046.
- 85P.H. Gorman, S.F. Qadri, A. Rao-Patel. Prophylactic inferior vena cava (IVC) filter placement may increase the relative risk of deep venous thrombosis after acute spinal cord injury. J Trauma. 2009; 66: 707–712.
- 86D.M. Becker, J.T. Philbrick, J.B. Selby. Inferior vena cava filters. Indications, safety, effectiveness. Arch Intern Med. 1992; 152: 1985–1994.
- 87R.F. Sing, S.M. Camp, B.T. Heniford, et al. Timing of pulmonary emboli after trauma: Implications for retrievable vena cava filters. J Trauma. 2006; 60: 732–734, discussion 734-735.
- 88F.B. Rogers. Venous thromboembolism in trauma patients: A review. Surgery. 2001; 130: 1–12.
- 89S.R. Shackford, R.C. Mackersie, T.L. Holbrook, et al. The epidemiology of traumatic death. A population-based analysis. Arch Surg. 1993; 128: 571–575.
- 90M.M. Knudson, D.G. Ikossi. Venous thromboembolism after trauma. Curr Opin Crit Care. 2004; 10: 539–548.
- 91E. Ginzburg, S.M. Cohn, J. Lopez, J. Jackowski, M. Brown, S.M. Hameed. Randomized clinical trial of intermittent pneumatic compression and low molecular weight heparin in trauma. Br J Surg. 2003; 90: 1338–1344.
- 92J.P. Stannard, R.R. Lopez-Ben, D.A. Volgas, et al. Prophylaxis against deep-vein thrombosis following trauma: A prospective, randomized comparison of mechanical and pharmacologic prophylaxis. J Bone Joint Surg Am. 2006; 88: 261–266.
- 93S. Fuchs, T. Heyse, G. Rudofsky, G. Gosheger, C. Chylarecki. Continuous passive motion in the prevention of deep-vein thrombosis: A randomised comparison in trauma patients. J Bone Joint Surg Br. 2005; 87: 1117–1122.
- 94M.H. Meissner, W.L. Chandler, J.S. Elliott. Venous thromboembolism in trauma: A local manifestation of systemic hypercoagulability?. J Trauma. 2003; 54: 224–231.
- 95F.B. Rogers, M.D. Cipolle, G. Velmahos, G. Rozycki, F.A. Luchette. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: The EAST practice management guidelines work group. J Trauma. 2002; 53: 142–164.
- 96D.S. Borer, A.J. Starr, C.M. Reinert, et al. The effect of screening for deep vein thrombosis on the prevalence of pulmonary embolism in patients with fractures of the pelvis or acetabulum: A review of 973 patients. J Orthop Trauma. 2005; 19: 92–95.
- 97M.D. Cipolle, R. Wojcik, E. Seislove, T.E. Wasser, M.D. Pasquale. The role of surveillance duplex scanning in preventing venous thromboembolism in trauma patients. J Trauma. 2002; 52: 453–462.
- 98M.N. Levine, G. Raskob, R.J. Beyth, C. Kearon, S. Schulman. Hemorrhagic complications of anticoagulant treatment: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126(3 Suppl): 287S–310S.
- 99T. Young, J. Aukes, R. Hughes, H. Tang. Vena caval filters for the prevention of pulmonary embolism. Cochrane Database Syst Rev. 2007; (3): CD006212.
- 100T.D. Girard, J.T. Philbrick, J. Fritz Angle, D.M. Becker. Prophylactic vena cava filters for trauma patients: A systematic review of the literature. Thromb Res. 2003; 112: 261–267.
- 101D.A. Spain, J.D. Richardson, H.C. PolkJr., T.M. Bergamini, M.A. Wilson, F.B. Miller. Venous thromboembolism in the high-risk trauma patient: Do risks justify aggressive screening and prophylaxis?. J Trauma. 1997; 42: 463–467, discussion 467-469.
- 102C.S. Joels, R.F. Sing, B.T. Heniford. Complications of inferior vena cava filters. Am Surg. 2003; 69: 654–659.
- 103J.L. Antevil, M.J. Sise, D.I. Sack, et al. Retrievable vena cava filters for preventing pulmonary embolism in trauma patients: A cautionary tale. J Trauma. 2006; 60: 35–40.
- 104C.C. Cothren, W.R. Smith, E.E. Moore, S.J. Morgan. Utility of once-daily dose of low-molecular-weight heparin to prevent venous thromboembolism in multisystem trauma patients. World J Surg. 2007; 31: 98–104.
- 105M.F. Given, B.C. McDonald, P. Brookfield, et al. Retrievable Gunther Tulip inferior vena cava filter: Experience in 317 patients. J Med Imaging Radiat Oncol. 2008; 52: 452–457.
- 106L.D. Faucher, K.M. Conlon. Practice guidelines for deep venous thrombosis prophylaxis in burns. J Burn Care Res. 2007; 28: 661–663.
- 107H.R. Buller, G. Agnelli, R.D. Hull, T.M. Hyers, M.H. Prins, G.E. Raskob. Antithrombotic therapy for venous thromboembolic disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126(3 Suppl): 401S–428S.
- 108J.P. Barret, P.G. Dziewulski. Complications of the hypercoagulable status in burn injury. Burns. 2006; 32: 1005–1008.
- 109J.D. Douketis, C. Gu, A. Piccioli, A. Ghirarduzzi, V. Pengo, P. Prandoni. The long-term risk of cancer in patients with a first episode of venous thromboembolism. J Thromb Haemost. 2009; 7: 546–551.
- 110Y.S. Arkel. Thrombosis and cancer. Semin Oncol. 2000; 27: 362–374.
- 111R. Descourt, G. Le Gal, F. Couturaud, et al. Recurrent venous thromboembolism under anticoagulant therapy: A high risk in adenocarcinoma?. Thromb Haemost. 2006; 95: 912–913.
- 112H.T. Sorensen, L. Mellemkjaer, J.H. Olsen, J.A. Baron. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000; 343: 1846–1850.
- 113H.K. Chew, T. Wun, D. Harvey, H. Zhou, R.H. White. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med. 2006; 166: 458–464.
- 114A. Alcalay, T. Wun, V. Khatri, et al. Venous thromboembolism in patients with colorectal cancer: Incidence and effect on survival. J Clin Oncol. 2006; 24: 1112–1118.
- 115J.A. Heit. Venous thromboembolism epidemiology: Implications for prevention and management. Semin Thromb Hemost. 2002; 28(Suppl 2): 3–13.
- 116J.A. Heit. Cancer and venous thromboembolism: Scope of the problem. Cancer Control. 2005; 12(Suppl 1): 5–10.
- 117D. Bergqvist, J.A. Caprini, O. Dotsenko, A.K. Kakkar, R.G. Mishra, T.W. Wakefield. Venous thromboembolism and cancer. Curr Probl Surg. 2007; 44: 157–216.
- 118G. Agnelli, G. Bolis, L. Capussotti, et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: The @RISTOS project. Ann Surg. 2006; 243: 89–95.
- 119D. Bergqvist, G. Agnelli, A.T. Cohen, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002; 346: 975–980.
- 120M.S. Rasmussen. Preventing thromboembolic complications in cancer patients after surgery: A role for prolonged thromboprophylaxis. Cancer Treat Rev. 2002; 28: 141–144.
- 121B.S. Gathof, S.M. Picker, J. Rojo. Epidemiology, etiology and diagnosis of venous thrombosis. Eur J Med Res. 2004; 9: 95–103.
- 122S.I. Noble, A. Nelson, C. Turner, I.G. Finlay. Acceptability of low molecular weight heparin thromboprophylaxis for inpatients receiving palliative care: Qualitative study. BMJ. 2006; 332: 577–580.
- 123L.D. Wagman, M.F. Baird, C.L. Bennett, et al. Venous thromboembolic disease. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2006; 4: 838–869.
- 124A.Y. Lee, M.N. Levine, R.I. Baker, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003; 349: 146–153.
- 125N. Martel, J. Lee, P.S. Wells. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: A meta-analysis. Blood. 2005; 106: 2710–2715.
- 126M.L. Linenberger. Catheter-related thrombosis: Risks, diagnosis, and management. J Natl Compr Canc Netw. 2006; 4: 889–901.
- 127M.J. Kovacs, S.R. Kahn, M. Rodger, et al. A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study). J Thromb Haemost. 2007; 5: 1650–1653.
- 128N.P. Nguyen, T.L. Borok, J. Welsh, V. Vinh-Hung. Safety and effectiveness of vascular endoprosthesis for malignant superior vena cava syndrome. Thorax. 2009; 64: 174–178.
- 129P. Prandoni, A.W. Lensing, A. Piccioli, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood. 2002; 100: 3484–3488.
- 130G. Meyer, Z. Marjanovic, J. Valcke, et al. Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: A randomized controlled study. Arch Intern Med. 2002; 162: 1729–1735.
- 131R.D. Hull, G.F. Pineo, R.F. Brant, et al. Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer. Am J Med. 2006; 119: 1062–1072.
- 132R.L. Schiff, S.R. Kahn, I. Shrier, et al. Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis. Chest. 2005; 128: 3364–3371.
- 133M.R. Hoppener, H.B. Ettema, C.P. Henny, C.C. Verheyen, H.R. Buller. Low incidence of deep vein thrombosis after knee arthroscopy without thromboprophylaxis: A prospective cohort study of 335 patients. Acta Orthop. 2006; 77: 767–771.
- 134C.B. Mantilla, T.T. Horlocker, D.R. Schroeder, D.J. Berry, D.L. Brown. Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty. Anesthesiology. 2003; 99: 552–560, discussion 555A.
- 135S.S. Nathan, K.A. Simmons, P.P. Lin, et al. Proximal deep vein thrombosis after hip replacement for oncologic indications. J Bone Joint Surg Am. 2006; 88: 1066–1070.
- 136M.R. Lassen, K.A. Bauer, B.I. Eriksson, A.G. Turpie. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: A randomised double-blind comparison. Lancet. 2002; 359: 1715–1720.
- 137A.G. Turpie, K.A. Bauer, B.I. Eriksson, M.R. Lassen. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: A randomised double-blind trial. Lancet. 2002; 359: 1721–1726.
- 138A.G. Turpie, K.A. Bauer, B.I. Eriksson, M.R. Lassen. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: A meta-analysis of 4 randomized double-blind studies. Arch Intern Med. 2002; 162: 1833–1840.
- 139B.I. Eriksson, K.A. Bauer, M.R. Lassen, A.G. Turpie. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med. 2001; 345: 1298–1304.
- 140M.P. Glotzbecker, C.M. Bono, K.B. Wood, M.B. Harris. Thromboembolic disease in spinal surgery: A systematic review. Spine (Phila Pa 1976). 2009; 34: 291–303.
- 141M.E. Huang, J.S. Johns, J. White, K. Sanford. Venous thromboembolism in a rehabilitation setting after major lower-extremity amputation. Arch Phys Med Rehabil. 2005; 86: 73–78.
- 142R.W. Zickler, V. Gahtan, T. Matsumoto, M.D. Kerstein. Deep venous thrombosis and pulmonary embolism in bilateral lower-extremity amputee patients. Arch Phys Med Rehabil. 1999; 80: 509–511.
- 143D.K. Chong, A. Panju. Deep venous thrombosis as a cause of stump swelling in two lower extremity amputee patients. Arch Phys Med Rehabil. 1993; 74: 1002–1003.
- 144M.T. Knight, R. Dawson. Effect of intermittent compression of the arms on deep venous thrombosis in the legs. Lancet. 1976; 2: 1265–1268.
- 145L.A. Killewich, M.A. Cahan, D.J. Hanna, et al. The effect of external pneumatic compression on regional fibrinolysis in a prospective randomized trial. J Vasc Surg. 2002; 36: 953–958.
- 146M.A. Cahan, D.J. Hanna, L.A. Wiley, D.K. Cox, L.A. Killewich. External pneumatic compression and fibrinolysis in abdominal surgery. J Vasc Surg. 2000; 32: 537–543.
- 147Brandstater ME, Roth EJ, Siebens HC. Venous thromboembolism in stroke: Literature review and implications for clinical practice. Arch Phys Med Rehabil 992;73:S379–S391.
- 148E. Skaf, P.D. Stein, A. Beemath, J. Sanchez, M.A. Bustamante, R.E. Olson. Venous thromboembolism in patients with ischemic and hemorrhagic stroke. Am J Cardiol. 2005; 96: 1731–1733.
- 149S.I. Kamran, D. Downey, R.L. Ruff. Pneumatic sequential compression reduces the risk of deep vein thrombosis in stroke patients. Neurology. 1998; 50: 1683–1688.
- 150D. Imberti, D. Prisco. Venous thromboembolism prophylaxis in medical patients: Future perspectives. Thromb Res. 2005; 116: 365–375.
10.1016/j.thromres.2005.01.001 Google Scholar
- 151R.J. Davenport, M.S. Dennis, I. Wellwood, C.P. Warlow. Complications after acute stroke. Stroke. 1996; 27: 415–420.
- 152R.L. Aptaker, E.J. Roth, G. Reichhardt, M.E. Duerden, C.E. Levy. Serum albumin level as a predictor of geriatric stroke rehabilitation outcome. Arch Phys Med Rehabil. 1994; 75: 80–84.
- 153J. Kelly, A. Rudd, R. Lewis, B.J. Hunt. Venous thromboembolism after acute stroke. Stroke. 2001; 32: 262–267.
- 154P. Sandercock, C. Counsell, S.L. Stobbs. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. Cochrane Database Syst Rev. 2005; (2): CD000119.
- 155R.L. Harvey, L.L. Lovell, N. Belanger, E.J. Roth. The effectiveness of anticoagulant and antiplatelet agents in preventing venous thromboembolism during stroke rehabilitation: A historical cohort study. Arch Phys Med Rehabil. 2004; 85: 1070–1075.
- 156G. Gubitz, P. Sandercock, C. Counsell. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev. 2004; (3): CD00002.
- 157A. Chamorro, N. Vila, A. Saiz, M. Alday, E. Tolosa. Early anticoagulation after large cerebral embolic infarction: A safety study. Neurology. 1995; 45: 861–865.
- 158P.C. Gregory, K.V. Kuhlemeier. Prevalence of venous thromboembolism in acute hemorrhagic and thromboembolic stroke. Am J Phys Med Rehabil. 2003; 82: 364–369.
- 159C. Mazzone, F. Chiodo Grandi, P. Sandercock, M. Miccio, R. Salvi. Physical methods for preventing deep vein thrombosis in stroke. Cochrane Database Syst Rev. 2004; (4): CD001922.
- 160P.W. Kamphuisen, G. Agnelli. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?. Thromb Res. 2007; 119: 265–274.
- 161C.M. Kearon, S.R. Kahn, G. Agnelli, S. Goldhaber, G.E. Raskob, A.J. Comerota. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133: 454S–545S.
- 162P.M. Bath, R. Iddenden, F.J. Bath. Low-molecular-weight heparins and heparinoids in acute ischemic stroke: A meta-analysis of randomized controlled trials. Stroke. 2000; 31: 1770–1778.
- 163P.W. Kamphuisen, G. Agnelli, M. Sebastianelli. Prevention of venous thromboembolism after acute ischemic stroke. J Thromb Haemost. 2005; 3: 1187–1194.
- 164J. Broderick, S. Connolly, E. Feldmann, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: A guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation. 2007; 116: e391–e413.
- 165A. Iorio, G. Agnelli. Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: A meta-analysis. Arch Intern Med. 2000; 160: 2327–2332.
- 166S. Schulman, R.J. Beyth, C. Kearon, M.N. Levine. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133: 257S–298S.
- 167R.D. Wilson, P.K. Murray. Cost-effectiveness of screening for deep vein thrombosis by ultrasound at admission to stroke rehabilitation. Arch Phys Med Rehabil. 2005; 86: 1941–1948.
- 168D.A. Reiff, R.N. Haricharan, N.M. Bullington, R.L. Griffin, G. McGwinJr, L.W. Rue3rd. Traumatic brain injury is associated with the development of deep vein thrombosis independent of pharmacological prophylaxis. J Trauma. 2009; 66: 1436–1440.
- 169W.H. Geerts, K.I. Code, R.M. Jay, E. Chen, J.P. Szalai. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994; 331: 1601–1606.
- 170S.L. Bratton, R.M. Chestnut, J. Ghajar, et al. Guidelines for the management of severe traumatic brain injury. V. Deep vein thrombosis prophylaxis. J Neurotrauma. 2007; 24(Suppl 1): S32–S36.
- 171S.A. Yablon, W.A. Rock, W.K. Ng, T.G. Nick, C.M. McGrath. Evidence for an acute-phase hypercoagulable state as a major risk factor for venous thromboembolic disease among rehabilitation admission with acquired brain injury. Am J Phys Med Rehabil. 2000; 79: 204–205.
- 172M.C. Carlile, S.A. Yablon, W.J. Mysiw, A.B. Frol, D. Lo, R. Diaz-Arrastia. Deep venous thrombosis management following traumatic brain injury: A practice survey of the traumatic brain injury model systems. J Head Trauma Rehabil. 2006; 21: 483–490.
- 173T.M. Hyers, G. Agnelli, R.D. Hull, et al. Antithrombotic therapy for venous thromboembolic disease. Chest. 2001; 119(1 Suppl): 176S–193S.
- 174J. Kim, M.M. Gearhart, A. Zurick, M. Zuccarello, L. James, F.A. Luchette. Preliminary report on the safety of heparin for deep venous thrombosis prophylaxis after severe head injury. J Trauma. 2002; 53: 38–42, discussion 43.
- 175J.M. Meythaler, W.S. Fisher, L.W. Rue, A. Johnson, L. Davis, R.C. Brunner. Screening for venous thromboembolism in traumatic brain injury: Limitations of D-dimer assay. Arch Phys Med Rehabil. 2003; 84: 285–290.
- 176S.A. Yablon, W.A. RockJr, T.G. Nick, M. Sherer, C.M. McGrath, K.H. Goodson. Deep vein thrombosis: Prevalence and risk factors in rehabilitation admissions with brain injury. Neurology. 2004; 63: 485–491.
- 177D. Prisco, E. Grifoni. The role of D-dimer testing in patients with suspected venous thromboembolism. Semin Thromb Hemost. 2009; 35: 50–59.
- 178D.X. Cifu, D.L. Kaelin, B.E. Wall. Deep venous thrombosis: Incidence on admission to a brain injury rehabilitation program. Arch Phys Med Rehabil. 1996; 77: 1182–1185.
- 179J.M. Meythaler, M.J. DeVivo, J.B. Hayne. Cost-effectiveness of routine screening for proximal deep venous thrombosis in acquired brain injury patients admitted to rehabilitation. Arch Phys Med Rehabil. 1996; 77: 1–5.
10.1016/S0003-9993(96)90210-5 Google Scholar
- 180R.B. Page, M.A. Spott, S. Krishnamurthy, C. Taleghani, V.M. Chinchilli. Head injury and pulmonary embolism: A retrospective report based on the Pennsylvania Trauma Outcomes study. Neurosurgery. 2004; 54: 143–148, discussion 148-149.
- 181L.C. Marras, W.H. Geerts, J.R. Perry. The risk of venous thromboembolism is increased throughout the course of malignant glioma: An evidence-based review. Cancer. 2000; 89: 640–646.
10.1002/1097-0142(20000801)89:3<640::AID-CNCR20>3.0.CO;2-E CAS PubMed Web of Science® Google Scholar
- 182A.T. Chan, A. Atiemo, L.K. Diran, et al. Venous thromboembolism occurs frequently in patients undergoing brain tumor surgery despite prophylaxis. J Thromb Thrombolysis. 1999; 8: 139–142.
- 183D.C. Walsh, A.K. Kakkar. Thromboembolism in brain tumors. Curr Opin Pulm Med. 2001; 7: 326–331.
- 184R.L. Ruff, J.B. Posner. Incidence and treatment of peripheral venous thrombosis in patients with glioma. Ann Neurol. 1983; 13: 334–336.
- 185D.Y. Wen, W.A. Hall. Complications of subcutaneous low-dose heparin therapy in neurosurgical patients. Surg Neurol. 1998; 50: 521–525.
- 186R.L. Macdonald, C. Amidei, G. Lin, et al. Safety of perioperative subcutaneous heparin for prophylaxis of venous thromboembolism in patients undergoing craniotomy. Neurosurgery. 1999; 45: 245–251, discussion 251-242.
- 187S. Constantini, A. Kanner, A. Friedman, et al. Safety of perioperative minidose heparin in patients undergoing brain tumor surgery: A prospective, randomized, double-blind study. J Neurosurg. 2001; 94: 918–921.
- 188G. Agnelli, F. Piovella, P. Buoncristiani, et al. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med. 1998; 339: 80–85.
- 189L.D. Dickinson, L.D. Miller, C.P. Patel, S.K. Gupta. Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery. 1998; 43: 1074–1081.
- 190T.A. Cage, K.R. Lamborn, M.L. Ware, et al. Adjuvant enoxaparin therapy may decrease the incidence of postoperative thrombotic events though does not increase the incidence of postoperative intracranial hemorrhage in patients with meningiomas. J Neurooncol. 2009; 93: 151–156.
10.1007/s11060-009-9886-4 Google Scholar
- 191S. Tetri, J. Hakala, S. Juvela, et al. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage. Thromb Res. 2008; 123: 206–212.
- 192A. Raabe, R. Gerlach, M. Zimmermann, V. Seifert. The risk of haemorrhage associated with early postoperative heparin administration after intracranial surgery. Acta Neurochir (Wien). 2001; 143: 1–7.
- 193S.Z. Goldhaber, K. Dunn, M. Gerhard-Herman, J.K. Park, P.M. Black. Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. Chest. 2002; 122: 1933–1937.
- 194R.P. Sharpe, R. Gupta, V.H. Gracias, et al. Incidence and natural history of below-knee deep venous thrombosis in high-risk trauma patients. J Trauma. 2002; 53: 1048–1052.
- 195T.S. Kiser, V.A. Stefans. Pulmonary embolism in rehabilitation patients: Relation to time before return to physical therapy after diagnosis of deep vein thrombosis. Arch Phys Med Rehabil. 1997; 78: 942–945.
10.1016/S0003-9993(97)90054-X Google Scholar
- 196S.R. Kahn, I. Shrier, C. Kearon. Physical activity in patients with deep venous thrombosis: A systematic review. Thromb Res. 2008; 122: 763–773.
- 197D. Aldrich, D.P. Hunt. When can the patient with deep venous thrombosis begin to ambulate?. Phys Ther. 2004; 84: 268–273.
- 198C.D. Ciccone. Clinical question: Does ambulation immediately following an episode of deep vein thrombosis increase the risk of pulmonary embolism?. Phys Ther. 2002; 82: 84–88.
- 199M. Aschwanden, K.H. Labs, H. Engel, et al. Acute deep vein thrombosis: Early mobilization does not increase the frequency of pulmonary embolism. Thromb Haemost. 2001; 85: 42–46.
- 200H. Partsch. Ambulation and compression after deep vein thrombosis: Dispelling myths. Semin Vasc Surg. 2005; 18: 148–152.
- 201H. Partsch, W. Blattler. Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin. J Vasc Surg. 2000; 32: 861–869.
- 202H.R. Kroll, I.R. Odderson, F.H. Allen. Deep vein thrombi associated with the use of plastic ankle-foot orthoses. Arch Phys Med Rehabil. 1998; 79: 576–578.
10.1016/S0003-9993(98)90075-2 Google Scholar
- 203Y. Hara. Deep venous thrombosis in stroke patients during rehabilitation phase. Keio J Med. 2008; 57: 196–204.
- 204J.B. Segal, M.B. Streiff, L.V. Hofmann, K. Thornton, E.B. Bass. Management of venous thromboembolism: A systematic review for a practice guideline. Ann Intern Med. 2007; 146: 211–222.
- 205L.A. Linkins, P.T. Choi, J.D. Douketis. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: A meta-analysis. Ann Intern Med. 2003; 139: 893–900.
- 206C.J. van Dongen, R. Vink, B.A. Hutten, H.R. Buller, M.H. Prins. The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: A meta-analysis. Arch Intern Med. 2003; 163: 1285–1293.
- 207G. Agnelli, P. Prandoni, M.G. Santamaria, et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. N Engl J Med. 2001; 345: 165–169.
- 208G. Palareti, B. Cosmi, C. Legnani, et al. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med. 2006; 355: 1780–1789.
- 209B. Cosmi, C. Legnani, M. Cini, G. Guazzaloca, G. Palareti. D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis. Thromb Haemost. 2005; 94: 969–974.
- 210P.M. Ridker, S.Z. Goldhaber, E. Danielson, et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med. 2003; 348: 1425–1434.
- 211C. Kearon, J.S. Ginsberg, M.J. Kovacs, et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med. 2003; 349: 631–639.
Citing Literature
